MedPath

ICATIBANT INJECTION

ICATIBANT INJECTION

Discontinued
DIN Number

02516608

Drug Class

Human

Market Date

N/A

Company
HC

Accord Healthcare Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02516608
AIG Number0155710001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B06AC02 ICATIBANT
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:32.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ICATIBANT (ICATIBANT ACETATE)Active
Strength: 30 MG / 3 ML
Monograph: ICATIBANT (ICATIBANT ACETATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.